Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer

Limitations of therapies exposed

Nature volume 484, pages 44–46 (2012)Cite this article

Subjects

Certain drugs that are used to treat cancer affect blood-vessel formation in tumours. But it seems that these antiangiogenic drugs can reduce the efficiency of other anticancer agents and increase the tumours' aggressiveness.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Drawbacks of anticancer therapies.

References

  1. Van der Veldt, A. A. M. et al. Cancer Cell 21, 82–91 (2012).

    Article  CAS  Google Scholar 

  2. Conley, S. J. et al. Proc. Natl Acad. Sci. USA 109, 2784–2789 (2012).

    Article  ADS  CAS  Google Scholar 

  3. Hurwitz, H. I. et al. J. Clin. Oncol. 23, 3502–3508 (2005).

    Article  CAS  Google Scholar 

  4. Jain, R. K. Nature Med. 7, 987–989 (2001).

    Article  CAS  Google Scholar 

  5. Jain, R. K. Science 307, 58–62 (2005).

    Article  ADS  CAS  Google Scholar 

  6. Willett, C. G. et al. Nature Med. 10, 145–147 (2004).

    Article  CAS  Google Scholar 

  7. Batchelor, T. T. et al. Cancer Cell 11, 83–95 (2007).

    Article  CAS  Google Scholar 

  8. Kamba, T. et al. Am. J. Physiol. Heart Circ. Physiol. 290, H560–H576 (2006).

    Article  CAS  Google Scholar 

  9. Sandler, A. et al. N. Engl. J. Med. 355, 2542–2550 (2006).

    Article  ADS  CAS  Google Scholar 

  10. Boehm, T., Folkman, J., Browder, T. & O'Reilly, M. S. Nature 390, 404–407 (1997).

    Article  ADS  CAS  Google Scholar 

  11. Bergers, G. & Hanahan, D. Nature Rev. Cancer 8, 592–603 (2008).

    Article  CAS  Google Scholar 

  12. Rini, B. I. & Atkins, M. B. Lancet Oncol. 10, 992–1000 (2009).

    Article  CAS  Google Scholar 

  13. Pàez-Ribes, M. et al. Cancer Cell 15, 220–231 (2009).

    Article  Google Scholar 

  14. Ebos, J. M. L. et al. Cancer Cell 15, 232–239 (2009).

    Article  CAS  Google Scholar 

  15. Charafe-Jauffret, E. et al. Clin. Cancer Res. 16, 45–55 (2010).

    Article  CAS  Google Scholar 

  16. Folkins, C. et al. Cancer Res. 67, 3560–3564 (2007).

    Article  CAS  Google Scholar 

  17. Korkaya, H. et al. PLoS Biol. 7, e1000121 (2009).

    Article  Google Scholar 

  18. Casazza, A. et al. EMBO Mol. Med. 4, 234–250 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oriol Casanovas is in the Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research, E-08907 L'Hospitalet de Llobregat, Spain.,

    Oriol Casanovas

Authors
  1. Oriol Casanovas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oriol Casanovas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Casanovas, O. Limitations of therapies exposed. Nature 484, 44–46 (2012). https://doi.org/10.1038/484044a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/484044a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer